Roivant Sciences

Roivant Sciences

Verified
Developing transformative medicines faster by building technologies and developing talent in creative ways

Company information

Edit
Launch date
Employees
Ownership
Firm valuation
$7.3b (Dealroom.co estimates Oct 2021.)
Revenues, earnings & profits over time
EUR201620172018201920202021E2022E
Revenues<1m<1m<1m----
% growth-(20 %)-----

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
$100mGrowth Equity VC
N/AGrowth Equity VC
*
$1.1b
Valuation: $5.6b
Growth Equity VC
$200m
Valuation: $7.0b
Growth Equity VC
$3.0bMerger
$200mGrowth Equity VC
$411m
Valuation: $7.3b
SPAC IPO
$200m
Valuation: $7.3b
SPAC Private Placement
Total Funding$1.8b

Recent News about Roivant Sciences

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Roivant Sciences

Edit